{"nct_id":"NCT04633278","title":"CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2021-01-21","start_date_type":"ACTUAL","primary_completion_date":"2024-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["REGN"]}